Glickman Mark A

CIK 0001441461

Chief Business OfficerDirector

Filings

Latest Jul 1, 2025

Issuers covered

Showing

5 of 5

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Glickman Mark A. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Glickman Mark A has filed

Ticker	Issuer	Filings	Last filed
NRBO	Neurobo Pharmaceuticals, Inc.	3	Jul 1, 2025
TXMD	Therapeuticsmd, Inc.	2	Mar 31, 2022

5 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Jul 1, 2025	NRBONeurobo Pharmaceuticals, Inc.	AGrant	28,147	$0.00	$0
Jun 7, 2024	NRBONeurobo Pharmaceuticals, Inc.	AGrant	5,051	$0.00	$0
Jul 28, 2023	NRBONeurobo Pharmaceuticals, Inc.	AGrant	25,000	$0.00	$0
Mar 31, 2022	TXMDTherapeuticsmd, Inc.	Holdings only	-	-	-
Mar 28, 2022	TXMDTherapeuticsmd, Inc.	Holdings only	-	-	-

Showing 1-5 of 5

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.